Company intelligence / Profile preview

Montalier International

Puteaux, France

Ownership: Private
Development stage: Other

Overview

Laboratoires Montalier was a French pharmaceutical company that specialized in the development of treatments for vascular and venous disorders. The company was most notably recognized for its flagship product, Ginkor Fort, a standardized medication used to treat symptoms of venous insufficiency and hemorrhoidal crises. In 1995, the company was acquired by Hoechst Marion Roussel (HMR), which subsequently became part of Aventis and later Sanofi. Today, the Montalier brand and its core products are fully integrated into Sanofi's consumer healthcare portfolio.

Therapeutic areas: CardiovascularGastroenterology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Montalier International.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Montalier International.

Explore the full profile